OverviewChartNewsTraderScreen

BVT Put 130 TGT 20.09.2024/  DE000VM7N9F3  /

EUWAX
2024-05-31  8:48:39 AM Chg.-0.038 Bid11:09:26 AM Ask11:09:26 AM Underlying Strike price Expiration date Option type
0.192EUR -16.52% 0.192
Bid Size: 11,000		 0.204
Ask Size: 11,000		 Target Corp 130.00 USD 2024-09-20 Put
TeleTrader 10:55 AM ECB's Panetta: Inflation expected to ease further
GlobeNewswire 10:28 AM Flash News: OKX Wallet Now Integrated with Stake DAO
GlobeNewswire 10:17 AM WOO X Lists $MEW and $TURBO on its Perpetuals Market
GlobeNewswire 9:44 AM WOO X Lists $PURSE on its Spot Market
GlobeNewswire 9:30 AM XTCC partners with Circulariti to support sustainability and carbon neutrality in the end to end fa...
GlobeNewswire 9:15 AM HSBC Continental Europe: Post Stabilisation Notice
GlobeNewswire 9:00 AM insightsoftware to Strengthen xP&A and Write-Back Capabilities in Qlik With Fiplana Acquisition
TeleTrader 8:57 AM China says not providing arms to any side in Ukraine conflict
TeleTrader 8:44 AM NATO chief: Kremlin escalation threat not new
GlobeNewswire 8:14 AM STMicroelectronics to build the world’s first fully integrated silicon carbide facility in Italy
GlobeNewswire 8:09 AM DePIN Mining Aggregator ‘Hivello’ Launches Private Beta Application
TeleTrader 8:00 AM Annual UK house prices up 1.3% in May
GlobeNewswire 8:00 AM Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional Shares
GlobeNewswire 7:54 AM Flash News: OKX Wallet Now Integrated with DIN
GlobeNewswire 7:30 AM Baosheng Media Group Holdings Limited Announces Filing of Current Report on Form 6-K with the SEC re...
TeleTrader 7:19 AM Asia-Pacific mostly higher after China, Japan data
GlobeNewswire 7:05 AM Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD
GlobeNewswire 7:05 AM Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD
GlobeNewswire 7:00 AM Update on FDA Priority Review of Dupixent® (dupilumab) for the Treatment of COPD Patients with Type ...
GlobeNewswire 7:00 AM Press Release: Update on FDA priority review of Dupixent for the treatment of COPD patients with typ...
GlobeNewswire 7:00 AM VEON discloses April YTD trading update at its AGM
GlobeNewswire 7:00 AM Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024
TeleTrader 6:30 AM N. Korea dismisses US, S. Korea's planned joint drills
GlobeNewswire 6:08 AM Sen. John Cornyn delivers remarks at Driscoll Children's Hospital Rio Grande Valley
GlobeNewswire 5:00 AM Flash News: OKX to List Ultiverse's Token on its Spot Market, Expanding Trading Options